Survival in Small-Cell Lung Cancer Improved With Cytotoxic Add-On to Immunotherapy

(MedPage Today) — CHICAGO — Patients with extensive-stage small-cell lung cancer (SCLC) lived significantly longer with the addition of cytotoxic agent lurbinectedin (Zepzelca) to maintenance immunotherapy, a large randomized trial showed…

Source link : https://www.medpagetoday.com/meetingcoverage/asco/115728

Author :

Publish date : 2025-05-22 21:00:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

Survival in Small-Cell Lung Cancer Improved With Cytotoxic Add-On to Immunotherapy

Mismatch Between Alzheimer’s Biomarkers and Symptoms May Signal Multiple Pathologies

FDA Approves Roflumilast Foam for Scalp, Body Psoriasis

Related Posts

New Clozapine Consensus Guidelines Drop ANC Monitoring

At-Home Alzheimer’s Testing Is Here: Are Physicians Ready?

An Elusive PCOS Diagnosis Could Explain Obesity Issues

Are You Asking These Seven Sexual Health Questions?

Direct Challenge Safe for Penicillin Allergy in Pregnancy

Woman smuggled baby into UK using fake birth story

New Clozapine Consensus Guidelines Drop ANC Monitoring

At-Home Alzheimer’s Testing Is Here: Are Physicians Ready?

An Elusive PCOS Diagnosis Could Explain Obesity Issues

Are You Asking These Seven Sexual Health Questions?

Direct Challenge Safe for Penicillin Allergy in Pregnancy

Woman smuggled baby into UK using fake birth story

Asthma Amplifies Allergic Rhinitis Burden in Children

LIGO has spotted the most massive black hole collision ever detected

Categories

Archives